Atlas Trials

Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma

Clinical trial NCT02626962 · COMPLETED

Trial details

NCT number
NCT02626962
Sponsor
Grupo Español Multidisciplinar de Melanoma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Uveal Melanoma
Start date
2016-04-01
Primary completion
2017-05-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.